A profile published last month in the New York Times on disgraced Theranos founder Elizabeth Holmes, who started her 11-year prison sentence Tuesday after defrauding investors with an ineffective blood-testing product, reportedly ignited an internal debate that paralleled one that occurred in the Twitter court of public opinion.
According to a Vanity Fair report Wednesday,…